Melius Pharma
PrivateLast Round
Series A
May 3, 2022
Est. Valuation
$4.66M
Total Funding Raised
$1.82M
Company Overview
Melius Pharma is a Swedish clinical-stage pharmaceutical company developing a therapy for Th2-associated refractory chronic cough (RCC).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Melius Pharma Comps
Public and private peers based on sector, stage, and business model.
Melius Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 3, 2022 |
Melius Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fåhraeus Startup and Growth | Series A |
| Linc AB | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 19, 2026
Monthly visitors increased 58% MoM.
- May 4, 2025
Monthly visitors grew 61% MoM, reaching 1.6K.
Melius Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Melius Pharma's valuation, stock price, and market status.
